|
Merck and Ridgeback's molnupiravir, an oral COVID-19 antiviral medicine, receives first authorization in the world
|
15 November 2021 |
|
Merck discontinues development of SARS-CoV-2/COVID-19 vaccine candidates; continues development of two investigational therapeutic candidates
|
25 January 2021 |
|
Merck to acquire Rigontec, RIG-I therapeutics pioneer, advancing leadership in immuno-oncology
|
08 September 2017 |
|
Merck launches Biosimilars Clarified, a new online educational resource about biosimilar medicines for patients and the healthcare community
|
17 October 2016 |
|
Merck receives Breakthrough Therapy Designation from FDA and PRIME status from EMA for investigational Ebola Zaire vaccine (V920)
|
26 July 2016 |
|
Merck launches Vivera in Latin America
|
20 January 2016 |
|
Merck Acquires IOmet Pharma and expands immuno-oncology development program
|
11 January 2016 |
|
Merck Establishes Joint Venture with Supera Farma
|
15 February 2012 |
|
Merck Publishes 2010 Global Corporate Responsibility Report
|
03 October 2011 |
|
Merck Statement on GARDASIL®
|
16 September 2011 |
|
Merck and Serum Institute Announce Collaboration
|
12 August 2011 |
|
ROTATEQ® (Rotavirus Vaccine, Live, Oral, Pentavalent) Awarded Prix Galien USA 2010 Top Honor
|
01 October 2010 |
|
Merck Receives Approval from FDA for Expanded Indications for Atypical Antipsychotic Medication SAPHRIS®
|
09 September 2010 |
|
Merck Provides New Funding to Fight HIV/AIDS in Botswana
|
25 August 2010 |
|
Single Treatment with ELONVA® Produced Live Birth Rates Comparable to Daily rFSH Injections
|
30 June 2010 |
|
New SIMPONI (Golimumab) Data Shows Sustained Efficacy in the Treatment of Rheumatoid Arthritis
|
23 June 2010 |
|
Merck Announces Launch of Pioneering Collaborative Cancer Trials Network
|
04 June 2010 |
|
Results of the clinical study CALYPSO Published in The Journal of Clinical Oncology
|
26 May 2010 |
|
Merck Positioned to Drive Growth Through Innovative Portfolio, Pipeline and Strategy
|
12 May 2010 |
|
Merck Announces First-Quarter 2010 Financial Results
|
05 May 2010 |